{"id":12533,"date":"2012-11-15T22:25:42","date_gmt":"2012-11-16T03:25:42","guid":{"rendered":"http:\/\/www.unionvilletimes.com\/?p=12533"},"modified":"2012-11-16T18:06:35","modified_gmt":"2012-11-16T23:06:35","slug":"drug-deception-to-cost-glaxosmithkline-90-million","status":"publish","type":"post","link":"https:\/\/www.unionvilletimes.com\/?p=12533","title":{"rendered":"Drug deception to cost GlaxoSmithKline $90 million"},"content":{"rendered":"<p><em><strong><span style=\"font-family: arial, helvetica, sans-serif; font-size: medium;\">State attorney general: Pa. will receive $4 million of Avandia settlement<\/span><\/strong><\/em><\/p>\n<div id=\"attachment_12534\" style=\"width: 260px\" class=\"wp-caption alignright\"><a href=\"http:\/\/www.unionvilletimes.com\/?attachment_id=12534\" rel=\"attachment wp-att-12534\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-12534\" class=\"size-full wp-image-12534 \" style=\"border-width: 2px; border-color: black; border-style: solid; margin: 4px;\" title=\"A-G-Linda-L-Kelly-1a-250x275\" src=\"http:\/\/www.unionvilletimes.com\/wp-content\/uploads\/2012\/11\/A-G-Linda-L-Kelly-1a-250x275.jpg\" alt=\"\" width=\"250\" height=\"275\" srcset=\"https:\/\/www.unionvilletimes.com\/wp-content\/uploads\/2012\/11\/A-G-Linda-L-Kelly-1a-250x275.jpg 250w, https:\/\/www.unionvilletimes.com\/wp-content\/uploads\/2012\/11\/A-G-Linda-L-Kelly-1a-250x275-90x100.jpg 90w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/a><p id=\"caption-attachment-12534\" class=\"wp-caption-text\">State Attorney General Linda Kelly announced that Pennsylvania will receive $4 million of a national $90 million settlement with GlaxoSmithKline.<\/p><\/div>\n<p>HARRISBURG \u2013Pennsylvania will receive more than $4 million as part of a national settlement with GlaxoSmithKline that resolves allegations that the company unlawfully promoted its diabetes drug, Avandia, Attorney General Linda Kelly announced today in a news release.<\/p>\n<p>The release said that GlaxoSmithKline, a British-based pharmaceutical company that operates worldwide, has agreed to pay $90 million to resolve allegations that the company engaged in unfair and deceptive practices by misrepresenting Avandia\u2019s cardiovascular risks and safety profile.<\/p>\n<p>As part of the consent judgment, GlaxoSmithKline agrees to reform how it markets and promotes diabetes drugs and agrees to avoid the following: making any false, misleading, or deceptive claims about any diabetes drug; making comparative safety claims not supported by substantial evidence or substantial clinical experience; presenting favorable information previously thought of as valid but rendered invalid by contrary and more credible recent information; promoting investigational drugs; or misusing statistics or otherwise misrepresent the nature, applicability, or significance of clinical trials, the release said.<\/p>\n<p><!--more-->The agreement also has the following terms that are effective for at least eight years: GlaxoSmithKline (GSK) must post summaries of all sponsored observational studies or meta-analyses conducted that are designed to inform the effective, safe, and\/or appropriate use of its diabetes drugs; GlaxoSmithKline shall post summaries of GSK-sponsored clinical trials of diabetes products within eight months of the primary completion date; GSK shall register and post all GSK-sponsored clinical trials as required by federal law; and GSK shall comply with the ICMJE Uniform Requirements for Manuscripts submitted to Biomedical Journals, according to the release.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>State attorney general: Pa. will receive $4 million of Avandia settlement HARRISBURG \u2013Pennsylvania will receive more than $4 million as part of a national settlement with GlaxoSmithKline that resolves allegations that the company unlawfully promoted its diabetes drug, Avandia, Attorney General Linda Kelly announced today in a news release. The release said that GlaxoSmithKline, a [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":12534,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,183],"tags":[1951,2230,2229],"class_list":["post-12533","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-business","tag-attorney-general-linda-kelly","tag-avandia","tag-glaxosmithkline"],"_links":{"self":[{"href":"https:\/\/www.unionvilletimes.com\/index.php?rest_route=\/wp\/v2\/posts\/12533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unionvilletimes.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unionvilletimes.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unionvilletimes.com\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unionvilletimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12533"}],"version-history":[{"count":0,"href":"https:\/\/www.unionvilletimes.com\/index.php?rest_route=\/wp\/v2\/posts\/12533\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.unionvilletimes.com\/index.php?rest_route=\/wp\/v2\/media\/12534"}],"wp:attachment":[{"href":"https:\/\/www.unionvilletimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unionvilletimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unionvilletimes.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}